DGAP-Adhoc: Updated guidance for the 2021/2022 financial year
2022. június 02., csütörtök, 15:14
DGAP-Ad-hoc: Borussia Dortmund GmbH & Co. KGaA / Key word(s): Change in Forecast On 25 February 2022 (see ad hoc disclosure from the same date), Borussia Dortmund published its forecast of a consolidated net loss of EUR 17.0 –24.0 million for the 2021/2022 financial year. This guidance can no longer be achieved. Borussia Dortmund now forecasts a consolidated net loss of EUR 25.0 – 29.0 million for the 2021/2022 financial year. The forecast deterioration of the earnings situation for the 2021/2022 financial year is due mainly to the premature departure of the former head coach and his coaching staff. Today, the parties reached an agreement in principle on the financial terms of the early termination of the employment contracts which were originally due to expire on 30 June 2024. In particular, this resulted in a one-off write-down in the mid-seven-digit range for the 2021/2022 financial year, which will nevertheless be fully offset by a corresponding decrease in write-downs over the two subsequent financial years. This new guidance is subject to any adjusting events that may occur in the period until the financial statements are finalised and information that eventually may arise after the reporting period during the audit of the consolidated financial statements for the 2021/2022 financial year. Dortmund, 02.06.2022 Borussia Dortmund GmbH & Co. KGaA Contact: Dr. Robin Steden Inhouse Counsel / Investor Relations
|
Language: | English |
Company: | Borussia Dortmund GmbH & Co. KGaA |
Rheinlanddamm 207 - 209 | |
44137 Dortmund | |
Germany | |
Phone: | 0231/ 90 20 - 2746 |
Fax: | 0231/ 90 20 - 852746 |
E-mail: | [email protected] |
Internet: | www.bvb.de/aktie // www.aktie.bvb.de |
ISIN: | DE0005493092 |
WKN: | 549309 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1367487 |
End of Announcement | DGAP News Service |
1367487 02-Jun-2022 CET/CEST
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]